The HIST1H2AG (Ab-29) Antibody is a polyclonal antibody developed against a peptide sequence surrounding residue Arg29 of human histone H2A type 1 (UniProt ID: P0C0S8). It is widely used to study epigenetic modifications, chromatin dynamics, and B-cell-mediated immune responses . This antibody targets the mono- or di-methylated Arg29 post-translational modification site, making it critical for investigating histone-associated transcriptional regulation .
Detects H2AK119ub (ubiquitinated histone H2A), a repressive chromatin mark linked to transcriptional silencing and DNA repair .
Validated in models studying B-cell intrinsic regulation of antibody-mediated immunity, where BAP1 deficiency alters H2AK119ub levels and disrupts plasma cell differentiation .
Used to analyze germinal center B-cell proliferation and class-switch recombination defects in Bap1 knockout murine models .
Critical for mapping histone modifications in activated B cells during humoral immune responses .
Applied in glioma tissue analysis (IHC) and HeLa cell immunofluorescence to study histone dynamics in cancer .
Detects aberrant H2A ubiquitination in myelodysplastic syndrome and T-cell dysfunction .
BAP1 (BRCA1-associated protein 1) regulates genome-wide H2AK119ub levels, which are essential for B-cell proliferation and antibody production .
Loss of BAP1 in B cells reduces plasma cell numbers by 90% and impairs antigen-specific IgG1 responses .
2A-HUB, an E3 ligase, specifically monoubiquitinates H2A at K119, repressing transcription by blocking RNA polymerase II release .
Overexpression of 2A-HUB increases H2AK119ub levels, while its inactive mutant (2A-HUBR) has no effect .